DAB389interleukin-7
Alternative Names: interleukin-7 diphtheria toxin chimeric protein; interleukin-7 fusion toxinLatest Information Update: 26 Jun 2001
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 23 Nov 1998 New profile
- 23 Nov 1998 Preclinical development for Cancer in USA (Unknown route)